ARTICLE SUMMARY:
Paul Yock reflects on his long career as a cardiologist-inventor and as the founder of Stanford's Biodesign program; Health Advances ponders the dividing line between medtech and digital health; embecta CEO Dev Kurdikar outlines his company's path to growth; we preview medtech legislative priorities for the new Congress, and profile Cardiokol, NeurOptrek, and X-trodes.
